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Abstract
Background: Drug therapy in high-risk individuals has been advocated as an important strategy
to reduce cardiovascular disease in low income countries. We determined, in a low-income urban
population, the proportion of persons who utilized health services after having been diagnosed as
hypertensive and advised to seek health care for further hypertension management.
Methods: A population-based survey of 9254 persons aged 25–64 years was conducted in Dar es
Salaam. Among the 540 persons with high blood pressure (defined here as BP ≥ 160/95 mmHg) at
the initial contact, 253 (47%) had high BP on a 4th visit 45 days later. Among them, 208 were
untreated and advised to attend health care in a health center of their choice for further
management of their hypertension. One year later, 161 were seen again and asked about their use
of health services during the interval.
Results: Among the 161 hypertensive persons advised to seek health care, 34% reported to have
attended a formal health care provider during the 12-month interval (63% public facility; 30%
private; 7% both). Antihypertensive treatment was taken by 34% at some point of time (suggesting
poor uptake of health services) and 3% at the end of the 12-month follow-up (suggesting poor long-
term compliance). Health services utilization tended to be associated with older age, previous
history of high BP, being overweight and non-smoking, but not with education or wealth. Lack of
symptoms and cost of treatment were the reasons reported most often for not attending health
care.
Conclusion: Low utilization of health services after hypertension screening suggests a small impact
of a patient-centered screen-and-treat strategy in this low-income population. These findings
emphasize the need to identify and address barriers to health care utilization for non-
communicable diseases in this setting and, indirectly, the importance of public health measures for
primary prevention of these diseases.
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Worldwide, 7.1 million deaths (12.8% of the total) and
64.3 million DALYs (4.4% of the total) were due to sub-
optimal blood pressure (BP) in 2000, and two thirds of
the disease burden attributable to hypertension already
occurs in the developing world [1]. It was estimated that
333 million adults had hypertension in economically
developed countries and 639 million in economically
developing countries [2]. In Tanzania, the mortality rate
from non-communicable disease at the age of 15–59 years
was markedly higher than in the UK [3], and a substantial
prevalence of high BP was found in the population [4],
including in our study area [5].
The efficacy of BP lowering medications is well demon-
strated [6,7] and treatment of high-risk individuals has
been advocated as a major strategy to curb non-communi-
cable diseases in all countries, including in developing
countries [8,9]. However, managing hypertension -or ele-
vated total cardiovascular risk- is challenging in low-
income countries for a variety of reasons, including drug
availability and costs, as well as inadequacy of health serv-
ices for identification and management of non-communi-
cable diseases and their risk factors [10,11]. Also,
individuals who struggle with a broad range of day-to-day
problems may discount the benefit of long-term treat-
ments for silent conditions that do not immediately jeop-
ardize their health.
Attendance of a health care provider ("uptake of health
services") is a first step that high-risk individuals must
comply with in order to possibly benefit from treatment.
Furthermore, uptake of health services should be followed
by continued use of such health services for long-term
treatment of hypertension and other non-communicable
diseases. Studies that have examined barriers to the use of
health services for the management of non-communica-
ble diseases in developing countries have often examined
this issue from the perspective of established users of
health services (i.e. patients already attending health serv-
ices) [12]. We are not aware of other studies that have
assessed the utilization of health services for the manage-
ment of non-communicable conditions in low-income
countries on the basis of a population-based study. Popu-
lation-based studies are essential to estimate the actual
impact of a screen-and-treat strategy at the population
level in such settings [8].
In this study, we examined the 12-month utilization of
health services for hypertension management upon
screening for hypertension in a large population-based
sample of adults of a large city in sub Saharan Africa. Our
reliance on hypertension alone (rather than on total car-
diovascular risk) recognizes that the diagnosis of hyper-
tension and long-term management of high BP can be
relatively inexpensive and feasible (in contrast to diagno-
sis and long-term management of other main cardiovas-
cular risk factors such as diabetes or dyslipidemia) and
that a hypertension-based screen-and-treat strategy can be
a practical entry point for the management of non-com-
municable diseases in low-resource settings. The second-
ary endpoint of this study was the identification of factors
associated with the utilization of health services for hyper-
tension.
Methods
Dar es Salaam, with approximately 4 million inhabitants,
is the economic center of Tanzania (about 40 millions
inhabitants). The United Republic of Tanzania is situated
on the East Coast of Africa, south of Kenya and north of
Mozambique. According to the World Bank, the GDP for
Tanzania was among the lowest worldwide (744 interna-
tional dollars – purchasing power parity- in 2006) and
total health expenditure amounted to only US$ 11.3 per
capita per year [13].
In Dar es Salaam, medical care for hypertension (and dia-
betes) is given mainly through specialized outpatient clin-
ics in government hospitals and in a few large public
health centers-hence not in all public health centers- as
well as in a few private hospitals and clinics. In 2005, sev-
eral anti-hypertensive medications could be found at
fairly similar prices in government and selected private
pharmacies. The minimal cost for a one-year treatment
was, for examples, US$1.5 for bendrofluazide (2.5 mg/
day), $15 for atenolol (50 mg/day), $60 for amlodipine
(5 mg/day) and $120 for captopril (50 mg/day) [14]. In
comparison, a laborer's average salary can amount to
US$30–50 per month. The 2000/01 Tanzanian House-
hold Budget Survey reports that the mean expenditure per
capita in Dar es Salaam was ~22 US$ per month, 2.9% of
which went to medical expenditure.
Methods of the baseline survey, participants' characteris-
tics and the distribution of BP and other risk factors in this
population have been reported previously [5,15]. Briefly,
eligible participants were all inhabitants aged 25–64 years
living in 5 contiguous branches of the Temeke municipal-
ity of Dar es Salaam, in a low-income area of the city. The
name and address of the inhabitants were available from
a census performed one year before the study took place,
as part of another health research program [3,16]. All
examinations for this study took place at the participants'
homes. Seventeen clinical officers, who had been trained
for the conduct of the survey, made up to 4 attempts to
meet the eligible participants at their home. In addition,
the clinical officers could benefit from the help of the
"ten-cell leaders" of the area (i.e. the persons administra-
tively in charge of areas of around 10 adjacent houses orPage 2 of 8
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facilitating contacts.
Structured questionnaires were administered to the partic-
ipants twice: i) at baseline("B" in Figure 1) and ii) at a fol-
low-up visit 12 months after the participants had been
screened for high BP and advised to seek health care for
further management of hypertension ("I"). The baseline
questionnaire inquired on socio-economic variables; life-
style factors; history of hypertension and diabetes; knowl-
edge, attitudes and practices related to cardiovascular risk
factors and diseases; and various other characteristics. A
wealth score (0 to 5) was constructed by adding 1 point
for the availability, at the participants' home, of any of the
following items: electricity (reported by 62% of inhabit-
ants), television (26%), refrigerator (29%), flush toilet
(15%) and private car (6%) [5]. Weight and height were
measured with portable instruments. Blood was not col-
lected and blood markers could not be assessed.
Humeral BP was measured with a validated automatic
device (Visomat 2, Hestia Pharma, Mannheim, Germany)
[17] with subjects in a sitting position. Three readings
were obtained at each visit. The first reading was measured
after a 5-minute rest and two subsequent readings were
taken at intervals of ≥ 2 minutes. "High BP" was defined
as systolic BP ≥ 160 mmHg and/or diastolic BP ≥ 95
mmHg based on the average of the last two of three read-
ings. All persons who had high BP on the 1st visit ("C" in
Figure) had BP measured on 3 additional visits within 45
days. The participants who had high BP on the 4th visit
were considered as having "hypertension". This high BP
cut off (≥ 160/95 mmHg) was chosen to maximize the
specificity of the "hypertension" diagnosis, to limit the
number of home visits during the 45-day period needed
to ascertain hypertension, and to ensure that detected
cases also had elevated total cardiovascular risk.
No intervention was provided until hypertension was
ascertained on the 4th visit. However, persons with diasto-
lic BP ≥ 220 mm hg and/or diastolic BP ≥ 120 mmHg on
any visit were advised to immediately report to a health
care facility and they were excluded from the study. On
the 4th visit, all participants were informed of their hyper-
tension status. All participants received a 10-minute
advice on healthy lifestyles and nutrition and their rele-
vance for BP control. In addition, persons with hyperten-
sion were told that i) they had hypertension, ii) they
would most probably need to take antihypertensive med-
ication on a long-term basis and iii) they should seek fur-
Study design (Rx: antihypertensive treatment)Figure 1
Study design (Rx: antihypertensive treatment).Page 3 of 8
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further management of their hypertension. In addition,
the survey officers gave to all hypertensive participants a
card with the participant's BP values on all 4 visits and a
written advice to report to a health care facility within the
next days. All survey officers were "clinical officers", i.e.
health professionals who have completed a 2-year medi-
cal training program and who constitute a main resource
for providing health care in government health centers in
Tanzania (including prescribing essential medications,
such as antihypertensive drugs).
All hypertensive participants who were not taking an anti-
hypertensive medication at baseline were administered a
follow-up questionnaire approximately 12 months later
to assess health services utilization during the 12-month
interval.
All participants were free to participate and verbal
informed consent was sought from each participant. The
study was approved by the National Institute of Medical
Research and by the Tanzanian Commission for Science
and Technology.
The main outcome of the study was the proportion of
untreated hypertensive participants who attended a
health care facility for the management of hypertension
during the 12-month interval after hypertension screening
and advice to seek health care. A secondary objective was
to identify factors associated with health care utilization.
Logistic regression was performed with minimal adjust-
ment (age and sex) in view of the small sample size avail-
able for this analysis. Analyses were performed using Stata
8.2 and data are presented with 95% confidence intervals.
Results
Participation is illustrated in Figure 1. Among the 9254
participants screened in the initial examination, high BP
(defined as systolic/diastolic BP ≥ 160/95 mmHg in this
study) was found in 582 individuals (6.3%) ("C"+"D" in
Figure 1). Hypertension (defined as BP ≥ 160/95 mmHg
on the 4th visit in our study) was confirmed in 251 partic-
ipants, i.e. in 47% of those with elevated BP on the first
visit ("F"+"G"). Among the 208 participants with hyper-
tension and who were not taking an antihypertension
medication at baseline ("F"), we could trace 161 (77%) of
them twelve months later ("I").
Table 1 shows that only 54 (34%) of the 161 hypertensive
participants who were advised to seek health care actually
attended a health care facility at least once during the 12-
month follow-up period. Among them, 63% attended a
public health care facility, 30% a private health care facil-
ity and 7% both.
Table 1 also shows that health care utilization was associ-
ated with older age (odds ratio 2.11, p < 0.05), being over-
weight (OR 2.1, p < 0.038), and marginally with smoking
(OR: 0.33 p < 0.094) and history of hypertension (OR
1.79, p < 0.081). There was a non-significant trend
towards larger health service utilization by women com-
pared to men. Health care utilization was not associated
with education, wealth, and BP level. The magnitude of
these associations was similar after adjustment for age and
sex, but only the association with age remained statisti-
cally significant.
Among the 161 hypertensive participants who could be
traced, 46 (29%) reported to have been prescribed some
antihypertensive treatment at some point during the 12-
month interval, 8 (5%) during the last month and 5 (3%)
on the last day (Figure 2). Among the 54 hypertensive per-
sons who visited a health care facility, as advised, 85%
took an antihypertensive treatment at some point during
the 12-month interval, but only 14% during the last
month and 9% on the last day. The proportion of partici-
pants taking antihypertensive medication on the last
month/day may represent the proportions of hypertensive
patients that are compliant over the long-term. The differ-
ence in BP before and after follow-up was not statistically
different in treated vs. non-treated participants, which was
anticipated in view of the small sample sizes.
Other results worth noting were found among the 161
hypertensive persons. Only 1 person reported to have
sought health care at a traditional practitioner and 6 at a
pharmacy (all of them also sought treatment at a regular
health care provider). Forty-seven percent reported that
hypertension was "very important" for them, 23% "mod-
erately important" and the remaining 30% "not impor-
tant". Asked about possible complications of
hypertension along an open-ended question, 89 (55%)
could not tell any but 29% mentioned stroke or paralysis
and another 9% reported death. To the question on how
long antihypertensive treatment should generally be
taken, 83% did not know. Among the 115 of 161 hyper-
tensive persons who did not attend health services for
hypertension, 40% reported that the main reason for not
seeking health care was the lack of symptoms associated
with raised BP and 15% mentioned the cost of health care
and treatment.
Discussion
This study shows that, in a fairly poor area of an urban
population of a low-income country, only one third of
hypertensive persons advised to seek health care upon
hypertension screening actually attended health services
at any time during a 12-month follow-up interval. Fur-
thermore, among those individuals who sought health
care, less than 10% were taking antihypertensive medica-Page 4 of 8
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an idea of both the uptake of health services upon screen-
ing of hypertension and the level of compliance with
long-term treatment. Overall, these findings may indicate
that the effectiveness of a community-based screen-and-
treat strategy is likely to be low in this setting.
Despite several limitations (see below), this study raises at
least two important points. The first is the way diagnosis
of hypertension should be made. The two-fold decrease of
the prevalence of high BP between the first and fourth vis-
its stresses again the need to measure BP several times on
each visit of several visits before the diagnosis of hyperten-
sion can be made. This allows to take into account the var-
iability of BP measures and the progressive habituation of
patients to BP measurement over time [15,18]. Identifying
false positive cases using repeated BP readings is impor-
tant everywhere to avoid unnecessary treatment, but this
is even more crucial in resource-limited settings. This
comment on BP measurements also applies for strategies
based on an individual's total cardiovascular risk [9].
The second point is related to the low utilization of health
services among persons identified as hypertensive after a
careful diagnosis and subsequent advice to seek appropri-
ate health care. Not only was the proportion of hyperten-
sive persons who actually attended health care at least
once low (one third), but an even smaller fraction (5%)
reported using an antihypertensive medication one year
later (suggesting a very low level of long-term compli-
ance). Low utilization of health care for hypertension in
our study is consistent with findings gathered in a study
conducted at health service level in the same area (munic-
ipality of Temeke; population of approximately 1 mil-
lion): among all 87,773 medical visits to all public and
private health services during a one-month period, only
817 visits were related to hypertension (and 440 to diabe-
tes) [14]. Our findings of a low utilization of health serv-
Table 1: Factors associated with utilization of health services for hypertension treatment after hypertension screening and advice to 
seek health care for hypertension management
Total with hypertension Attended a health facility Univariate association Adjusted for age and sex
N % CI OR CI P OR CI P
Total 161 33.5 (26–49)
Sex
Men 60 28.3 (17–40) 1 1
Women 101 36.6 (27–46) 1.46 (0.7–2.9) ns 1.55 (0.8–3.1) ns
Age
25–44 63 23.8 (13–35) 1 1
45–64 98 39.7 (30–50) 2.11 (1.1–4.3) 0.038 2.19 (1.1–.4.5) 0.031
Education
None 53 39.6 (26–52) 1 1
Primary 81 30.8 (21–41) 0.72 (0.3–1.4) ns 0.93 (0.4–2.0) ns
Secondary 27 29.6 '(11–48) 0.64 (0.2–1.7) ns 0.81 (0.3–2.3) ns
Wealth score
0 76 34.2 (23–45) 1 1
1–2 56 32.1 (20–45) 0.91 (0.5–1.8) ns 1.08 (0.5–2.3) ns
3–5 29 34.5 (16–53) 1.01 (0.4–2.5) ns 1.08 (0.4–2.7) ns
History of HBP
No 90 27.8 (18–37) 1 1
Yes 71 40.8 (29–52) 1.79 (0.9–2.3) 0.081 1.53 (0.8–3.0) ns
Blood pressure
< 180/110 119 33.6 (25–42) 1 1
≥ 180/110 42 33.3 (19–48) 0.98 (0.5–2.0) ns 0.83 (0.4–1.8) ns
Diabetes
No 157 33.7 (26–41) 1 1
Yes 4 25.0 (0–100) 1.50 (0.2–15.0) ns 2.19 (0.2–22) ns
Overweight
No 62 24.1 (13–32) 1 1
Yes 69 39.2 (30–49) 2.10 (1.1–4.3) 0.038 1.99 (1.0–4.2) 0.069
Smoking
No 142 35.9 (28–43) 1 1
Yes 19 15.7 (0–33) 0.33 (0.1–1.2) 0.094 0.34 (0.1–1–3) ns
OR: odds ratio; CI: 95% confidence interval.Page 5 of 8
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very low proportions with BP controlled (BP < 140/90
mmHg) among hypertensives treated in population-
based cross-sectional studies in many developing coun-
tries [4,19]. This proportion was as low as 2.6% in men
and 4.3% in women in the population of this study [5].
Attendance of health care is a necessary first step to get
appropriate health care for hypertension treatment. Low
uptake of health services for the management of hyperten-
sion may reflect barriers related to the individuals (e.g.,
lack of awareness on hypertension, low priority given to
asymptomatic conditions, competing priorities, costs, cul-
tural factors, etc); health personnel (e.g. skills to ade-
quately treat non-communicable diseases and underlying
training); health systems (e.g. inadequate structures, inef-
ficient organization, insufficient resources for health care
of chronic conditions); and, more generally, a restricted
focus on BP lowering programs and health policies in
countries facing a double burden of communicable and
non-communicable diseases [10,11]. Of note, the obser-
vations in this study correspond to a situation in which
some organized health care exists for the diagnosis and
treatment of hypertension (e.g. hypertension clinics in
several hospitals and in some large health centers) and
where anti-hypertensive medications can be purchased at
all times (both in public and private pharmacies). This
contrasts with many rural areas where such services are
not available.
The marked decrease of persons under antihypertensive
treatment over the 12-month follow-up interval points to
poor compliance to long-term medication for an asymp-
tomatic condition. However, a low proportion of patients
under treatment at the end of the 12-month interval is not
necessarily equivalent to poor adherence to treatment by
the individuals. Patients may not be advised by their doc-
tor (or nurse or clinical officer) to take a medication on a
long-term basis. Low long-term use of antihypertensive
treatment is also consistent with a common belief by the
patients that hypertension can be treated with medica-
tions given for a few days only (as found in our study).
Similarly, it is not unusual that hypertensive patients are
treated with bed rest and short term medication (e.g. i.v.
furosemide) only or antihypertensive medications are
prescribed for just a few days or weeks. The cost of medi-
cations also remains a problem. Except for bendrofluazide
(~US$1.5 for 12-month treatment), antihypertensive
Proportion of all untreated hypertensive participants at baseline (n = 161) who attended health services for hypertension treat-ment and/or received antihypertensive tre tment after hyp rtension screening nd a vice to seek health care for hypertension a agementFigur  2
Proportion of all untreated hypertensive participants at baseline (n = 161) who attended health services for 
hypertension treatment and/or received antihypertensive treatment after hypertension screening and advice 
to seek health care for hypertension management.Page 6 of 8
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wages [14]. However, in a study conducted in a middle-
income country in the African region, good adherence to
a simple one-pill antihypertensive regimen was only 26%
one year after treatment was started, despite the fact that
health care and medications were provided without direct
fees to the patients [20].
Although this study was not primarily designed to identify
factors associated with this poor performance, our data
suggest that older age and past history of high BP could be
predictive factors for health care utilization, consistent
with other reports [21]. The lack of an association with
education or wealth was unexpected. However it must be
emphasized that the upper education and/or wealth cate-
gories in this poor area actually correspond to fairly low
absolute levels. Findings could have been different if the
range of education and wealth categories had been larger
in the population. We found a trend toward lower health
care utilization for hypertension treatment among smok-
ers than non-smokers. We could speculate that this may
reflect lower concern for health among smokers than non-
smokers. An inverse relationship between health care uti-
lization and smoking would be a matter of concern since
smoking substantially increases the risk of cardiovascular
disease and hypertensive smokers would therefore most
benefit from antihypertensive treatment.
The study has several limitations. First, the stringent defi-
nition of hypertension in this study underestimated the
true proportion of hypertension in the population (the
proportion of persons with BP ≥ 140/90 mmHg in this
population is described elsewhere [5]). However, the high
cut off for hypertension used in this study (close to "grade
2" hypertension according to current guidelines [18]),
ensured, on one hand, that most cases were truly hyper-
tensive and, on the other hand, that most hypertensive
cases were at increased total cardiovascular risk irrespec-
tive of other risk factors and therefore eligible for treat-
ment. Most guidelines – including for the African region
[22] – indeed recommend medication therapy in case of
either high total cardiovascular risk or very high BP alone.
Admittedly, further studies should examine the utilization
of health services based on standard cut-off values for
hypertension and using an explicit total risk approach to
treatment. Second, we excluded participants under anti-
hypertensive treatment at baseline. However, including
them would not have markedly changed our conclusions
since only few participants were taking antihypertensive
treatment at baseline and some of them also might have
dropped treatment during the one-year follow-up. Third,
the participation rates at both the baseline and follow-up
examinations seemed suboptimal. However, a character-
istic of this poor urban study setting is that the population
is rapidly changing, which is complicating the concept of
the resident population. A sub-study in this area showed
that, during a one-year period, 21% had moved outside of
the area, 4.8% were traveling (sometimes for months) to
their village or to take up some occasional work else-
where, 3.8% had died, and the fate of 4.2% was unknown
[5]. Hence, it is likely that our follow-up study has
included most of the adults continuously living in the
area during the 12-month follow up interval. Fourth, one
may question the generalization of a screening program
performed at home vs. within usual health service
premises. It is however likely that the location of the
screening at home had less influence than other factors
that can impact on individuals' behaviors to actually seek
further health care or not (cost, expected benefit of treat-
ment, competing priorities, etc). Finally, with regards to
our secondary aim of identifying correlates of health serv-
ices utilization, we ended up with a fairly small number of
hypertensive persons who attended a health facility for
hypertension management (n = 161) despite having
screened a large population (n = 9254), which limited the
statistical power of these association analyses.
Conclusion
In conclusion, our data suggest that the low uptake of
health services for hypertension management and poor
compliance to long-term treatment strongly limit the
impact of a patient-centered screen-and-treat strategy in a
low-income population. The current shift of focus in
recent guidelines from a treatment approach based on sin-
gle risk factors (such as hypertension in our study) to a
treatment approach based on total cardiovascular risk
[8,9] does not lessen the meaning of our findings and con-
clusions, since the utilization of health services is a neces-
sary step in all instances. Furthermore, screening and
treatment of hypertension may well be a most feasible
and affordable therapeutic approach for increased cardio-
vascular risk in this setting. Low utilization of health serv-
ices for hypertension treatment (and likely for the
management of other chronic non-communicable condi-
tions) is an important message for those in charge of the
implementation of high-risk strategies in developing
countries, as recently described in a series of seminal
papers on non-communicable diseases in low income
countries [8] and elsewhere [9]. Our study also empha-
sizes the need to identify and address barriers to effective
delivery of health care for non-communicable diseases in
low-resource settings [23]. The example of Cuba, another
low-income country, provides some encouraging clues:
hypertension control rates are among the highest world-
wide [24], likely a response to a strong primary health care
system and the local production of antihypertensive med-
ications, among other factors. More generally, the subop-
timal impact of a patient-centered treatment strategy
further stresses the need to develop, experiment, and
implement public health measures targeting the entirePage 7 of 8
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diseases [25].
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